- Home
- FG vs MANE Comparison
FG vs MANE Comparison
Compare FG & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FG | MANE |
|---|---|---|
| Founded | 1959 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.4B |
| IPO Year | 2023 | 2026 |
Fundamental Metrics
Financial Performance| Metric | FG | MANE |
|---|---|---|
| Price | $26.57 | $108.20 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $31.00 | ★ $83.33 |
| AVG Volume (30 Days) | 574.6K | ★ 747.4K |
| Earning Date | 05-06-2026 | 03-30-2026 |
| Dividend Yield | ★ 3.52% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.24 | N/A |
| Revenue | ★ $5,731,000,000.00 | N/A |
| Revenue This Year | $7.94 | N/A |
| Revenue Next Year | $5.51 | N/A |
| P/E Ratio | $21.37 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $20.57 | $36.26 |
| 52 Week High | $35.60 | $131.24 |
Technical Indicators
Market Signals| Indicator | FG | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 38.42 | 48.16 |
| Support Level | $26.45 | $104.45 |
| Resistance Level | $29.77 | $116.68 |
| Average True Range (ATR) | 0.92 | 5.79 |
| MACD | -0.29 | -0.03 |
| Stochastic Oscillator | 10.72 | 70.13 |
Price Performance
Historical ComparisonAbout FG F&G Annuities & Life Inc.
F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.
About MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.